Viracta Therapeutics Inc Forecast, price target & analysts
$0.02
0.00%
today
Nasdaq,
Feb 28, 06:29 pm CET
Viracta Therapeutics Inc Target price 2025 - Analyst rating & recommendation
Powered by
Viracta Therapeutics Inc Classifications & Recommendation:
Hold
100%
Viracta Therapeutics Inc Price Target
| Target Price | $0.25 |
| Price | $0.02 |
| Potential |
986.96%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a Viracta Therapeutics Inc price target 2026.
The average Viracta Therapeutics Inc target price is $0.25.
This is
986.96%
register free of charge
|
|
| A rating was issued by 1 analysts: 0 Analysts recommend Viracta Therapeutics Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Viracta Therapeutics Inc stock has an average upside potential 2026 of
986.96%
register free of charge
|
Current Viracta Therapeutics Inc Upgrades & Downgrades Beta
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Rodman & Renshaw | Locked ➜ Locked | Locked | Dec 27 2024 |
| RBC Capital | Locked ➜ Locked | Locked | Nov 14 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Rodman & Renshaw: Locked ➜ Locked
|
Dec 27 2024 |
|
Locked
RBC Capital: Locked ➜ Locked
|
Nov 14 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
